Private Equity
Palo Alto, California-based Mindstrong Health, a healthcare company focused on measuring brain health, secured $15 million in Series B financing. The investors in this round included Bezos Expeditions, Decheng Capital, Optum Ventures, ARCH Venture Partners and Foresite Capital.
1 min read · 14 June 2018
Samsung Next, which builds software and services for Samsung, has launched a new fund. Samsung NEXT Q Fund will invest in AI-focused startups.
3 min read · 14 June 2018
True Ventures is seeking to raise $325 million for its sixth fund, according to an SEC filing. Silicon Valley-based True Ventures invests in early-stage tech startups.
1 min read · 14 June 2018
San Francisco-based Benchling, provider of a data management and collaboration platform for life sciences research, announced it has raised a $14.5 million Series B round of funding. Benchmark led the financing and General Partner Eric Vishria will join the company board. Also joining the round are F-Prime Capital, which is a firm associated with Fidelity Investments, and returning investor Thrive Capital. The company has now raised more than $27 million since it was founded in 2012.
1 min read · 14 June 2018
3 min read · 13 June 2018
2 min read · 13 June 2018
Los Angeles and Singapore-based Wavemaker Partners, an early-stage venture firm, has raised $4.3 million for its fifth fund, according to an SEC filing. The target is $75 million.
1 min read · 13 June 2018
Business Development Bank of Canada (BDC) and Export Development Canada (EDC) have launched a two-year program to provide $50 million in new financing to Canadian technology companies engaged in, or planning to engage in, an international business. Companies will be able to access working capital loans of up to $1 million. BDC and EDC will also refer clients to each other to increase capital access and networking opportunities. Federal Innovation Minister Navdeep Bains said the initiative will give technology companies "strong partners to help them scale up and tap into international markets."
4 min read · 13 June 2018
2 min read · 13 June 2018
Cambridge, Massachusetts-based Imara Inc, a clinical-stage biopharmaceutical company, has named Dr. Rahul D. Ballal as CEO. Previously, Ballal was at Northern Biologics and Versant Ventures where he was chief business officer and an entrepreneur-in-residence, respectively. Imara is backed by New Enterprise Associates, Pfizer Venture Investments, Lundbeckfond Ventures, Bay City Capital and Alexandria Venture Investments.
4 min read · 13 June 2018
